BR9910936A - Preparações aquosas semi-sólidas para a aplicação oral de toltrazuril-sulfona - Google Patents
Preparações aquosas semi-sólidas para a aplicação oral de toltrazuril-sulfonaInfo
- Publication number
- BR9910936A BR9910936A BR9910936-0A BR9910936A BR9910936A BR 9910936 A BR9910936 A BR 9910936A BR 9910936 A BR9910936 A BR 9910936A BR 9910936 A BR9910936 A BR 9910936A
- Authority
- BR
- Brazil
- Prior art keywords
- toltrazuryl
- sulfone
- oral application
- weight
- solid preparations
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 2
- 239000007787 solid Substances 0.000 title abstract 2
- 150000003457 sulfones Chemical class 0.000 title abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- 150000001253 acrylic acids Chemical class 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000012423 maintenance Methods 0.000 abstract 1
- 238000006116 polymerization reaction Methods 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 230000002335 preservative effect Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Glass Compositions (AREA)
Abstract
Patente de Invenção:<B>"PREPARAçõES AQUOSAS SEMI-SóLIDAS PARA A APLICAçãO ORAL DE TOLTRAZURIL-SULFONA"<D>. A presente invenção refere-se a pastas de toltrazuril-sulfona, administráveis de maneira oral, contendo substância ativa em uma concentração de 0,1 - 20% em peso e um tamanho de grão de 1 até 10 x 10^ -6^ m, poli (ácidos acrílicos) com um grau de polimerização de cerca de 3 x 10^ 6^ em uma concentração de 0,1 - 5% em peso, bem como, eventualmente, substâncias conservantes e agentes de manutenção da umidade e o restante para 100% em peso de água.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19824483A DE19824483A1 (de) | 1998-06-02 | 1998-06-02 | Halbfeste wäßrige Zubereitungen für orale Applikation von Toltrazuril-Sulfon |
PCT/EP1999/003462 WO1999062519A1 (de) | 1998-06-02 | 1999-05-20 | Halbfeste wässrige zubereitungen für orale applikation von toltrazuril-sulfon |
Publications (2)
Publication Number | Publication Date |
---|---|
BR9910936A true BR9910936A (pt) | 2001-03-06 |
BR9910936B1 BR9910936B1 (pt) | 2010-11-16 |
Family
ID=7869584
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI9910936-0A BR9910936B1 (pt) | 1998-06-02 | 1999-05-20 | pasta de toltrazuril-sulfona e processo para sua preparação. |
Country Status (18)
Country | Link |
---|---|
US (1) | US6436935B1 (pt) |
EP (1) | EP1091740B1 (pt) |
JP (1) | JP4958336B2 (pt) |
KR (1) | KR100717832B1 (pt) |
CN (1) | CN1137687C (pt) |
AT (1) | ATE279926T1 (pt) |
AU (1) | AU756372B2 (pt) |
BR (1) | BR9910936B1 (pt) |
CA (1) | CA2333680C (pt) |
DE (2) | DE19824483A1 (pt) |
DK (1) | DK1091740T3 (pt) |
ES (1) | ES2232143T3 (pt) |
HK (1) | HK1038702B (pt) |
HU (1) | HU228500B1 (pt) |
NZ (1) | NZ508513A (pt) |
PL (1) | PL193534B1 (pt) |
PT (1) | PT1091740E (pt) |
WO (1) | WO1999062519A1 (pt) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6150361A (en) * | 1998-12-22 | 2000-11-21 | Bayer Corporation | Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma |
DE10040174A1 (de) * | 2000-08-17 | 2002-02-28 | Bayer Ag | Verwendung von Triazintrion-Sulfonen zur Bekämpfung von Coccidiosen |
DE10040110A1 (de) * | 2000-08-17 | 2002-02-28 | Bayer Ag | Verwendung von Triazintrion-Sulfoxiden zur Bekämpfung von Coccidiosen |
DE102004001558A1 (de) * | 2004-01-10 | 2005-08-18 | Bayer Healthcare Ag | Arzneimittel zur topischen Applikation bei Tieren |
DE102007025908A1 (de) | 2007-06-01 | 2008-12-04 | Bayer Healthcare Ag | Formulierungen enthaltend Triazinone und Eisen |
SI22751A (sl) * | 2008-04-03 | 2009-10-31 | Krka, D.D., Novo Mesto | Toltrazuril z izboljĺ animi lastnostmi za raztapljanje |
DE102009012423A1 (de) * | 2009-03-10 | 2010-09-16 | Bayer Animal Health Gmbh | Zubereitung auf Ölbasis |
EP2740469A1 (en) | 2012-12-07 | 2014-06-11 | Ceva Sante Animale | New treatments with triazines |
EP2740492A1 (en) | 2012-12-07 | 2014-06-11 | Ceva Sante Animale | Triazine formulations with a second active ingredient and surfactant(s) |
EP2740470A1 (en) | 2012-12-07 | 2014-06-11 | Ceva Sante Animale | Treatment of Coccidiosis with intramuscular triazine composition |
EP3578182A1 (en) | 2018-06-05 | 2019-12-11 | Bayer Animal Health GmbH | Formulations containing triazinones and iron with a low amount of free iron ions |
EP3578181A1 (en) | 2018-06-05 | 2019-12-11 | Bayer Animal Health GmbH | Formulation for use in the simultaneous treatment of coccidial infections and iron deficiencies |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2718799A1 (de) * | 1977-04-27 | 1978-11-09 | Bayer Ag | 1-(4-phenoxy-phenyl)-1,3,5-triazin- derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel und wachstumsfoerderer |
DE3300793A1 (de) * | 1983-01-12 | 1984-07-12 | Bayer Ag, 5090 Leverkusen | Coccidiosemittel |
US4755386A (en) * | 1986-01-22 | 1988-07-05 | Schering Corporation | Buccal formulation |
DE19519821A1 (de) | 1995-05-31 | 1996-12-05 | Bayer Ag | Mittel gegen parasitäre Protozoen |
DE19603984A1 (de) * | 1996-02-05 | 1997-08-07 | Bayer Ag | Granulate von Triazinen |
US5883095A (en) * | 1997-08-07 | 1999-03-16 | University Of Kentucky Research Foundation | Formulations and methods to treat and prevent equine protozoal myeloencephalitis |
BR9808114A (pt) * | 1997-03-31 | 2000-03-08 | David Granstrom | Formulação de ração para cavalos utilizável para tratar epm, processos para tratar pm em um cavalo que necessita deste tratamento, para prevenir infecção com s. neutrona em cavalos, e, para exterminar s. neurona em cavalos |
-
1998
- 1998-06-02 DE DE19824483A patent/DE19824483A1/de not_active Withdrawn
-
1999
- 1999-05-20 EP EP99926343A patent/EP1091740B1/de not_active Expired - Lifetime
- 1999-05-20 US US09/701,087 patent/US6436935B1/en not_active Expired - Lifetime
- 1999-05-20 DK DK99926343T patent/DK1091740T3/da active
- 1999-05-20 WO PCT/EP1999/003462 patent/WO1999062519A1/de not_active Application Discontinuation
- 1999-05-20 NZ NZ508513A patent/NZ508513A/xx not_active IP Right Cessation
- 1999-05-20 AT AT99926343T patent/ATE279926T1/de active
- 1999-05-20 PL PL99344329A patent/PL193534B1/pl unknown
- 1999-05-20 PT PT99926343T patent/PT1091740E/pt unknown
- 1999-05-20 CA CA002333680A patent/CA2333680C/en not_active Expired - Lifetime
- 1999-05-20 JP JP2000551775A patent/JP4958336B2/ja not_active Expired - Lifetime
- 1999-05-20 CN CNB998069302A patent/CN1137687C/zh not_active Expired - Lifetime
- 1999-05-20 KR KR1020007012499A patent/KR100717832B1/ko not_active IP Right Cessation
- 1999-05-20 AU AU43642/99A patent/AU756372B2/en not_active Expired
- 1999-05-20 BR BRPI9910936-0A patent/BR9910936B1/pt not_active IP Right Cessation
- 1999-05-20 HU HU0102007A patent/HU228500B1/hu unknown
- 1999-05-20 ES ES99926343T patent/ES2232143T3/es not_active Expired - Lifetime
- 1999-05-20 DE DE59910906T patent/DE59910906D1/de not_active Expired - Lifetime
-
2002
- 2002-01-16 HK HK02100359.3A patent/HK1038702B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HK1038702A1 (en) | 2002-03-28 |
ATE279926T1 (de) | 2004-11-15 |
AU756372B2 (en) | 2003-01-09 |
JP2002516862A (ja) | 2002-06-11 |
ES2232143T3 (es) | 2005-05-16 |
EP1091740A1 (de) | 2001-04-18 |
US6436935B1 (en) | 2002-08-20 |
JP4958336B2 (ja) | 2012-06-20 |
PL193534B1 (pl) | 2007-02-28 |
AU4364299A (en) | 1999-12-20 |
EP1091740B1 (de) | 2004-10-20 |
CA2333680C (en) | 2009-05-19 |
KR20010043453A (ko) | 2001-05-25 |
HK1038702B (zh) | 2004-12-10 |
HUP0102007A2 (hu) | 2001-11-28 |
DE59910906D1 (de) | 2004-11-25 |
BR9910936B1 (pt) | 2010-11-16 |
HU228500B1 (en) | 2013-03-28 |
CN1304310A (zh) | 2001-07-18 |
PT1091740E (pt) | 2004-12-31 |
PL344329A1 (en) | 2001-10-22 |
KR100717832B1 (ko) | 2007-05-11 |
CA2333680A1 (en) | 1999-12-09 |
CN1137687C (zh) | 2004-02-11 |
HUP0102007A3 (en) | 2003-10-28 |
WO1999062519A1 (de) | 1999-12-09 |
NZ508513A (en) | 2002-09-27 |
DE19824483A1 (de) | 1999-12-09 |
DK1091740T3 (da) | 2005-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9910936A (pt) | Preparações aquosas semi-sólidas para a aplicação oral de toltrazuril-sulfona | |
ES2176502T3 (es) | Derivados de hidroxilamina utiles para mejorar la pproduccion de chaperonas moleculares su su preparacion. | |
ATE361084T1 (de) | Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis | |
FI20055562A (fi) | Alfa-interferonin stabiilit vesiliuosformulaatit | |
ES2188214T3 (es) | Composicion antioxidante que comprende acetil l-carnitina y acido alfa-lipoico. | |
RU94046143A (ru) | Фармацевтическая композиция для лечения глаукомы | |
TR200003688T1 (tr) | Glutation'un absorbsıyonu'nun arttırılması ve etkilerinin güçlendirilmesi için kompozisyon | |
BR0015416A (pt) | Composições contendo derivados do ácido hidroxieicosa tetraenóico e métodos de uso no tratamento de distúrbios de olhos secos | |
BR9707154A (pt) | Modulaç o da express o de citocina em th1/th2 por ribavirina e análogos de ribavirina em linfócitos t ativados | |
ES2340363T3 (es) | Metodo y composicion para el tratamiento de la neuropatia diabetica. | |
DK1401422T3 (da) | Halogenholdig sammensætning, fremgangsmåde til fremstilling heraf og anvendelser heraf | |
DE3669106D1 (de) | Pharmazeutische zusammensetzungen mit gehalt an flavanolignanen und phospholipiden als wirkstoffe. | |
BR9904613A (pt) | Utilização de uma goma de silicone, composição tópica e utilização de uma composição | |
DE69822452D1 (de) | Stabilisierte humane papillomaviruszusammensetzungen | |
ATE268181T1 (de) | Pharmazeutische zubereitungen enthaltend alginate | |
UY27373A1 (es) | Formulaciones de interferón beta-humano | |
EP0712630A3 (fr) | Composition orale pour la prévention des allergies solaires à base d'un caroténoide, d'un tocophérol, d'acide ascorbique et de sélénium | |
BR0108405A (pt) | Agente de ativação de célula | |
DK1220678T3 (da) | Farmaceutiske præparater indeholdende kobber, salicylsyre og C-vitamin | |
RU2006109966A (ru) | Препарат "янтастим-с" для терапии и профилактики инфекционных заболеваний животных | |
WO1994005255A1 (en) | Skin moisturizer compositions containing dimethylsulphydryl group releasing agent | |
ATE368383T1 (de) | Gewürzkrautzubereitung | |
RU97118541A (ru) | Мазевая композиция, стимулирующая регенерацию эпителия | |
BR0215498A (pt) | Composição farmacêutica compreendendo uma glitazona e um ácido 4-oxobutanóico e o seu uso para o tratamento de diabetes | |
BR0215352A (pt) | Composição farmacêutica que compreende um inibidor de alfa-glicosidase e um ácido 4-oxobutanóico, e seu uso para tratar diabetes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: ALTERADA DE INT.CL.8: A61K 47/32, A61K 31/53, A61P 33/02 Ipc: A61K 31/53 (2008.04), A61K 47/32 (2008.04) |
|
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B25A | Requested transfer of rights approved |
Owner name: BAYER ANIMAL HEALTH GMBH (DE) Free format text: TRANSFERIDO DE: BAYER AKTIENGESELLSCHAFT |
|
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 16/11/2010, OBSERVADAS AS CONDICOES LEGAIS. |
|
B25A | Requested transfer of rights approved |
Owner name: BAYER INTELLECTUAL PROPERTY GMBH (DE) |
|
B21A | Patent or certificate of addition expired [chapter 21.1 patent gazette] |
Free format text: PATENTE EXTINTA EM 16.11.2020 |